| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $512K | — | +62.0% |
| Gross Profit | -$11.4M | — | +46.0% |
| R&D Expense | $7.0M | — | +8.9% |
| SG&A Expense | $9.2M | — | -32.8% |
| Operating Income | -$35.9M | — | +18.1% |
| Interest Expense | $2.5M | — | +7.6% |
| Pre-tax Income | -$42.3M | — | -311.9% |
| Income Tax | $19K | — | +90.0% |
| Net Income | -$38.9M | — | -278.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.2M | -65.0% | +29.3% |
| Accounts Receivable | $273K | +6.2% | -58.9% |
| Inventory | $1.5M | -55.0% | -94.6% |
| Current Assets | $41.9M | -38.8% | -45.2% |
| Total Assets | $250.1M | -10.0% | -39.1% |
| Current Liabilities | $117.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$31.5M | -1383.1% | -55.1% |
| Capital Expenditures | $221K | — | -85.9% |
| Investing Cash Flow | $1.3M | +108.0% | +181.3% |
| Financing Cash Flow | $7.8M | +341.1% | -68.2% |
| Free Cash Flow | -$31.7M | — | -45.0% |
| -37.5% |
| Total Liabilities | $230.9M | -14.5% | -14.7% |
| Stockholders' Equity | -$12.4M | +54.7% | -108.9% |